StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Interest Received by Quarter

Interest Received ($M)

QuarterlyAnnual

Novartis Interest Received: $65M in Q3 2026, up 6.6% from a year earlier.

Latest, Q3 2026
65
Period ended Sep 30, 2026
Change on a year earlier
+6.6%
61 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Interest received | 65 | 61”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInterest Received ($M)Year on yearSource
Q3 2026Sep 30, 202665+6.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202644+12.8%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202683-32.0%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202588-38.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202561-45.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202539-45.1%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 2025122-25.6%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 2024142-12.9%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024112+2.8%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202471-39.3%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 2024164-35.9%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023163+22.6%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 2023109+32.9%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023117+457.1%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023256+1,405.9%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022133+2,560.0%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Interest Received ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-interest-rcvd

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.